Shanmuga Hospital IPO GMP, Kostak Rates & Subject to Sauda Rates
Stay updated with the latest Grey Market Premium (GMP), Kostak rates, and Subject to Sauda rates for the Shanmuga Hospital IPO. Currently, the GMP for Shanmuga Hospital IPO has not started. Keep checking for real-time updates.
Shanmuga Hospital IPO Overview
Shanmuga Hospital IPO is set to open on February 13, 2025. This SME IPO aims to raise ₹20.62 crores through a fixed price issue. The IPO price band is ₹54 per share, with a lot size of 2,000 shares.
Shanmuga Hospital IPO GMP & Kostak Rates (Live Updates)
Date | IPO GMP | Kostak | Subject to Sauda |
---|---|---|---|
8 Feb | ₹- | ₹- | ₹- |
![Shanmuga Hospital IPO GMP](https://ipogenius.in/wp-content/uploads/2025/02/Shanmuga-Hospital-IPO-GMP-1024x536.png)
Shanmuga Hospital IPO Details
Particulars | Details |
---|---|
IPO Open Date | February 13, 2025 |
IPO Close Date | February 17, 2025 |
Face Value | ₹10 Per Equity Share |
IPO Price Band | ₹54 Per Share |
Issue Size | Approx ₹20.62 Crores |
Fresh Issue | Approx ₹20.62 Crores |
Issue Type | Fixed Price Issue |
IPO Listing | BSE SME |
Retail Quota | Not more than 50% |
NII Quota | Not more than 50% |
Shanmuga Hospital IPO Important Dates
Event | Date |
---|---|
IPO Open Date | February 13, 2025 |
IPO Close Date | February 17, 2025 |
Basis of Allotment | February 18, 2025 |
Refunds | February 19, 2025 |
Credit to Demat | February 19, 2025 |
IPO Listing Date | February 20, 2025 |
FAQs – Shanmuga Hospital IPO GMP & Rates
- What is the Shanmuga Hospital IPO GMP today?
- The GMP is currently ₹-.
- What is the Shanmuga Hospital IPO Kostak Rate today?
- The Kostak Rate is ₹-.
- What is the Subject to Sauda rate today?
- The Subject to Sauda rate is ₹-.
- What are the expected returns from the Shanmuga Hospital IPO?
- Expected returns are currently unavailable.
Disclaimer:
The IPO Grey Market Premium (GMP) mentioned is based on the latest available data. GMP rates are subject to fluctuations and should not be the sole factor in investment decisions. Investors are advised to consider company fundamentals before subscribing.